Editorial

Letters from sitting editors of the JPDS. Topics may be chosen upon the discretion of the editor.


Putting the spotlight on skin of color

Johannes F. Dayrit, MD, FPDS

My fascination with pigmentary disorders started in 2015 when I gave a lecture titled “Controversial 50 shades of grey”, in one of the pre-congress sessions during the World Congress of Dermatology in Vancouver. The special meeting was a global consensus forum on conditions that are considered rare but may be found on pigmented skin such as ashy dermatosis, erythema dyschromicum perstans, lichen planus pigmentosus, Riehl’s melanosis and idiopathic eruptive macular pigmentation. After a series of discussions and E-mail communications among members of the group, a consensus on terminologies was formulated and the report is now awaiting publication.

PUBLICATIONS IN DERMATOLOGY: TRENDS, CONTROVERSIES AND THE FUTURE OF THE JPDS

Johannes F. Dayrit, MD, FPDS

At the 12th International Congress of Dermatology in Buenos Aires, Dr. Stephen Katz, in his keynote lecture “Molecular Dermatology: Progress and promise”, shared the leading advancements in dermatology. He revealed prospects for gene, protein and stem cell therapy for Recessive Epidermolysis Bullosa, the discovery of BRAF inhibitors that prolong the life of patients with melanoma, and new findings in autoinflammatory diseases and Pharmacogenomics. Ten to fifteen years ago, these major breakthroughs in genetics, molecular biology and targeted therapies would be unimaginable. Their discovery has since significantly impacted the scientific community.